Published in Immunology on September 01, 1989
Clonogenic mast cell progenitors and their excess numbers in chimeric BALB/c mice with inactivated GATA-1. Proc Natl Acad Sci U S A (2007) 0.78
The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci (1966) 9.68
The cloning of normal "mast" cells in tissue culture. J Cell Physiol (1965) 5.47
In vitro control of the development of macrophage and granulocyte colonies. Proc Natl Acad Sci U S A (1966) 4.13
Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci U S A (1986) 3.34
Mast cells in rat gastrointestinal mucosa. I. Effects of fixation. Acta Pathol Microbiol Scand (1966) 3.24
The induction of clones of normal mast cells by a substance from conditioned medium. Exp Cell Res (1966) 3.01
P cell-stimulating factor: biochemical characterization of a new T cell-derived factor. J Immunol (1981) 1.50
Intestinal mucosal mast cells from rats infected with Nippostrongylus brasiliensis contain protease-resistant chondroitin sulfate di-B proteoglycans. J Immunol (1986) 1.45
[ON THE SELECTIVE ENZYME-CYTOCHEMICAL DEMONSTRATION OF NEUTROPHILIC MYELOID CELLS AND TISSUE MAST CELLS IN PARAFFIN SECTIONS]. Klin Wochenschr (1964) 1.35
The enzymatic degradation of heparin and heparitin sulfate. 3. Purification of a heparitinase and a heparinase from flavobacteria. J Biol Chem (1970) 1.34
Analysis of polysulfated chondroitin disaccharides by high-performance liquid chromatography. Anal Biochem (1984) 1.05
IL-3-dependent growth of basophil-like cells and mastlike cells from human bone marrow. J Immunol (1989) 1.02
Mucosal mast cells in the rat and in man. Int Arch Allergy Appl Immunol (1987) 1.01
The presence of mast cells in agar cultures. Exp Hematol (1980) 0.92
An improved method for the histochemical demonstration of histamine and other compounds producing fluorophores with o-phthaldialdehyde. J Histochem Cytochem (1972) 0.86
Oversulfated chondroitin sulfate proteoglycan in cultured human peritoneal macrophages. Biochem Biophys Res Commun (1986) 0.84
Identification and characterization of human hemopoietic mast cell colonies. Exp Hematol (1988) 0.82
Scanning electron microscope observations on surface changes occurring in murine granulocytes and macrophages during maturation in soft agar cultures. Exp Hematol (1981) 0.79
Post bone marrow transplant sera and persisting mast cell colonies. Bone Marrow Transplant (1988) 0.79
Bone marrow as a potential source of hepatic oval cells. Science (1999) 8.52
Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res (2001) 4.87
Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci U S A (1995) 3.85
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest (2007) 3.58
Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. J Allergy Clin Immunol (1988) 3.57
Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods (1995) 3.54
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med (1987) 2.59
The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin Exp Allergy (2007) 2.44
Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood (1999) 2.38
Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology (1998) 2.21
Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci U S A (1991) 2.17
Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A (1999) 2.14
A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis. J Allergy Clin Immunol (1989) 2.03
Worldwide prevalence of lentivirus infection in wild feline species: epidemiologic and phylogenetic aspects. J Virol (1992) 1.93
Calcium homeostasis and parturient hypocalcemia: an integral feedback perspective. J Theor Biol (2002) 1.78
Mast cells in innate immunity. Immunol Rev (2000) 1.76
Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. J Immunol (1992) 1.70
Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol (1991) 1.69
The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest (1995) 1.63
The mast cell. Crit Rev Immunol (1981) 1.56
Ultrastructural, biochemical, and functional characteristics of histamine-containing cells cloned from mouse bone marrow: tentative identification as mucosal mast cells. J Immunol (1983) 1.50
Isolation and characterization of heparin from human lung. J Clin Invest (1979) 1.46
Flow cytometric analysis for cytokine production identifies T helper 1, T helper 2, and T helper 0 cells within the human CD4+CD27- lymphocyte subpopulation. J Immunol (1995) 1.42
Spin correlations in the paramagnetic phase and ring exchange in La2CuO4. Phys Rev Lett (2005) 1.40
C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol (1996) 1.37
Mastocytosis: current concepts in diagnosis and treatment. Ann Hematol (2002) 1.37
Putative site for the acquisition of human herpesvirus 6 virion tegument. J Virol (1990) 1.37
IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J Immunol (1993) 1.35
Phagocytosis of mast cell granules by cultured fibroblasts. J Immunol (1983) 1.34
Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis. Exp Hematol (2000) 1.34
Stem cell factor induces mast cell adhesion to fibronectin. J Immunol (1994) 1.28
The protooncogene c-kit and c-kit ligand in human disease. J Allergy Clin Immunol (1997) 1.27
Mast cell-T cell interactions. J Allergy Clin Immunol (1999) 1.26
Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: Up-regulation by IFN-gamma. J Immunol (2000) 1.23
Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase. J Clin Invest (1981) 1.23
Evaluation of immediate adverse reactions to foods in adult patients. II. A detailed analysis of reaction patterns during oral food challenge. J Allergy Clin Immunol (1985) 1.23
NIH conference. Asthma. Ann Intern Med (1994) 1.22
Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells. Blood (2001) 1.21
Allergy and the chronic fatigue syndrome. J Allergy Clin Immunol (1988) 1.21
Regulation of human mast cell tryptase. Effects of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides. Biochem J (1987) 1.19
Identification of tropomyosin as the major shrimp allergen and characterization of its IgE-binding epitopes. J Immunol (1993) 1.18
Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population. Blood (1994) 1.17
Food allergies. JAMA (1992) 1.16
An avidin--biotin microELISA for rapid measurement of total and allergen-specific human IgE. J Immunol Methods (1983) 1.15
Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides. Arthritis Rheum (1986) 1.10
Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. Gastroenterology (1988) 1.09
Patterning of sodium ions and the control of electrons in sodium cobaltate. Nature (2007) 1.07
Kit signal transduction. Hematol Oncol Clin North Am (2000) 1.07
Modeling stem cell population growth: incorporating terms for proliferative heterogeneity. Stem Cells (2003) 1.06
Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin. Eur J Immunol (2000) 1.06
Polydispersity of rat mast cell heparin. Implications for proteoglycan assembly. J Biol Chem (1980) 1.05
Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol (1997) 1.05
Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis. Cancer (1998) 1.05
Human eosinophil adherence to serum-treated sepharose: granule-associated enzyme release and requirement for activation of the alternative complement pathway. J Immunol (1977) 1.05
Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy. Arthritis Rheum (1987) 1.04
Mouse heparin proteoglycan. Synthesis by mast cell-fibroblast monolayers during lymphocyte-dependent mast cell proliferation. J Biol Chem (1982) 1.04
Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin-6 protein. J Allergy Clin Immunol (1992) 1.04
Neutrophil function and energy status in Holstein cows with uterine health disorders. Vet Immunol Immunopathol (2006) 1.04
Early expression of high-affinity receptor for immunoglobulin E (Fc epsilon RI) during differentiation of mouse mast cells and human basophils. J Clin Invest (1990) 1.03
Field testing of prophylactic measures against Cryptosporidium parvum infection in calves in a California dairy herd. Am J Vet Res (1996) 1.03
IL-3-dependent growth of basophil-like cells and mastlike cells from human bone marrow. J Immunol (1989) 1.02
Mast cell heterogeneity: evidence and implications. J Clin Immunol (1984) 1.01
Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol (1997) 1.00
IL-3-dependent mast cells attach to plate-bound vitronectin. Demonstration of augmented proliferation in response to signals transduced via cell surface vitronectin receptors. J Immunol (1992) 1.00
TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin. Mol Immunol (2005) 1.00
Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. Am J Med (1991) 1.00
An association between susceptibility to experimental autoimmune uveitis and choroidal mast cell numbers. J Immunol (1984) 0.99
Degradation of the heparin matrix of mast cell granules by cultured fibroblasts. J Immunol (1983) 0.99
Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. J Clin Invest (1997) 0.98
Frequency and characterization of antigen-specific IL-4- and IL-13- producing basophils and T cells in peripheral blood of healthy and asthmatic subjects. J Allergy Clin Immunol (1999) 0.98
Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism. Clin Exp Allergy (2011) 0.98
Suppression of thermal conductivity by rattling modes in thermoelectric sodium cobaltate. Nat Mater (2013) 0.98
Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J Leukoc Biol (1998) 0.98
Interactions between mast cells, fibroblasts and connective tissue components. Int Arch Allergy Appl Immunol (1985) 0.97
Regulation of adhesion of mouse bone marrow-derived mast cells to laminin. J Immunol (1990) 0.97
Pediatric mastocytosis. J Invest Dermatol (1991) 0.97
The Kit-activating mutation D816V enhances stem cell factor--dependent chemotaxis. Blood (2001) 0.97
Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB. Blood (1999) 0.96
Identification of an amino acid sequence in the laminin A chain mediating mast cell attachment and spreading. Immunology (1991) 0.96
Laminin promotes mast cell attachment. J Immunol (1989) 0.96
Arthritis and mast cell activation. J Allergy Clin Immunol (1990) 0.96
A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis. Bone Marrow Transplant (2006) 0.95
IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma. Eur J Immunol (2001) 0.95
Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and gamma-interferon (gamma-IFN) in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis. J Clin Immunol (1994) 0.95
Paediatric mastocytosis. Arch Dis Child (2002) 0.95
Endothelins belong to the assortment of mast cell-derived and mast cell-bound cytokines. New Biol (1992) 0.95
Pregnancy and lactation increase vitamin D-dependent intestinal membrane calcium adenosine triphosphatase and calcium binding protein messenger ribonucleic acid expression. Endocrinology (1998) 0.94
Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial. Am J Med (1985) 0.94
Transforming growth factor-beta prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation. J Immunol (1994) 0.94
The role of c-Kit and its ligand, stem cell factor, in mast cell apoptosis. Int Arch Allergy Immunol (1995) 0.94
Inhibition of IgE-mediated mast cell degranulation by sulphasalazine. Eur J Pharmacol (1985) 0.94
Gastrointestinal mast cells in health and disease. Part II. J Pediatr (1983) 0.93
Murine mast cells synthesize basement membrane components. A potential role in early fibrosis. J Clin Invest (1991) 0.93